These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 9138348)

  • 21. Immunohistochemical evaluation of thymidylate synthase (TS) and p16INK4a in advanced colorectal cancer: implication of TS expression in 5-FU-based adjuvant chemotherapy.
    Kamoshida S; Matsuoka H; Ishikawa T; Maeda K; Shimomura R; Inada K; Tsutsumi Y
    Jpn J Clin Oncol; 2004 Oct; 34(10):594-601. PubMed ID: 15591457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
    Poplin EA; Benedetti JK; Estes NC; Haller DG; Mayer RJ; Goldberg RM; Weiss GR; Rivkin SE; Macdonald JS
    J Clin Oncol; 2005 Mar; 23(9):1819-25. PubMed ID: 15774775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The current status of postoperative adjuvant chemotherapy for colorectal cancer].
    Kodaira S
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1230-8. PubMed ID: 9279341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
    Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
    J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population-based registration of unselected colorectal cancer patients: five-year survival in the region of Bonn/Rhine-Sieg, Germany.
    Lamberti C; Di Blasi K; Archut D; Fimmers R; Mathiak M; Bollmann M; Vogel J; Kindermann D; Mezger J; Schmidt-Wolf IG; Sauerbruch T
    Z Gastroenterol; 2005 Feb; 43(2):149-54. PubMed ID: 15700204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer of the colon and rectum.
    Catalano MF; Levin B
    Clin Geriatr Med; 1991 May; 7(2):331-46. PubMed ID: 1855162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indication and efficacy of adjuvant chemotherapy with oral fluoropyrimidines for dukes' B colorectal cancer.
    Yoshimatsu K; Umehara A; Ishibashi K; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
    Anticancer Res; 2006; 26(4B):3089-93. PubMed ID: 16886639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant therapy in colorectal cancer.
    Parshad R
    Trop Gastroenterol; 1997; 18(4):139-44. PubMed ID: 9612092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of adjuvant therapy in large bowel cancer.
    Davis HL; Kisner DL
    Cancer Clin Trials; 1978; 1(4):273-87. PubMed ID: 391429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group.
    Glimelius B; Dahl O; Cedermark B; Jakobsen A; Bentzen SM; Starkhammar H; Grönberg H; Hultborn R; Albertsson M; Påhlman L; Tveit KM;
    Acta Oncol; 2005; 44(8):904-12. PubMed ID: 16332600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinoma.
    Witte RS; Cnaan A; Mansour EG; Barylak E; Harris JE; Schutt AJ
    Cancer; 2001 Mar; 91(5):1020-8. PubMed ID: 11251955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.
    Ahnen DJ; Feigl P; Quan G; Fenoglio-Preiser C; Lovato LC; Bunn PA; Stemmerman G; Wells JD; Macdonald JS; Meyskens FL
    Cancer Res; 1998 Mar; 58(6):1149-58. PubMed ID: 9515799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colorectal cancer patterns of care in the Western Sydney and Wentworth Area Health Services.
    Barton MB; Gabriel GS; Miles S
    ANZ J Surg; 2004 Jun; 74(6):406-12. PubMed ID: 15191469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A patient's race/ethnicity does not explain the underuse of appropriate adjuvant therapy in colorectal cancer.
    McGory ML; Zingmond DS; Sekeris E; Bastani R; Ko CY
    Dis Colon Rectum; 2006 Mar; 49(3):319-29. PubMed ID: 16475031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III.
    Taal BG; Van Tinteren H; Zoetmulder FA;
    Br J Cancer; 2001 Nov; 85(10):1437-43. PubMed ID: 11720425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Surgery and multidisciplinary treatment for colorectal cancer].
    Sakamoto J; Kato J; Yasue M
    Gan To Kagaku Ryoho; 1998 Jan; 25(2):208-15. PubMed ID: 9474930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant therapy with the monoclonal antibody Edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage III colon cancer.
    Fields AL; Keller A; Schwartzberg L; Bernard S; Kardinal C; Cohen A; Schulz J; Eisenberg P; Forster J; Wissel P
    J Clin Oncol; 2009 Apr; 27(12):1941-7. PubMed ID: 19273708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical impact of adjuvant chemotherapy on patients with stage III colorectal cancer: l-LV/5FU chemotherapy as a modified RPMI regimen is an independent prognostic factor for survival.
    Hotta T; Takifuji K; Arii K; Yokoyama S; Matsuda K; Higashiguchi T; Tominaga T; Oku Y; Yamaue H
    Anticancer Res; 2006; 26(2B):1425-32. PubMed ID: 16619554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.
    Haller DG; Catalano PJ; Macdonald JS; O'Rourke MA; Frontiera MS; Jackson DV; Mayer RJ
    J Clin Oncol; 2005 Dec; 23(34):8671-8. PubMed ID: 16314627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.